<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">335935</id>
  <title nil="true"/>
  <common-name>[(1r,21s)-3-hydroxy-16,17-dimethoxy-13-methyl-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaen-21-yl] acetate</common-name>
  <description>[(1r,21s)-3-hydroxy-16,17-dimethoxy-13-methyl-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaen-21-yl] acetate is a compound with the formula C23H26NO7+. It has an average molecular weight of 428.50 g/mol.</description>
  <cas nil="true"/>
  <pubchem-id>86278052</pubchem-id>
  <chemical-formula>C23H26NO7+</chemical-formula>
  <weight>428.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T18:12:30Z</created-at>
  <updated-at type="dateTime">2026-08-30T18:12:30Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(=O)OC1C2C3=C(C4=C(C=C3CC[N+]2(CC5=C1C=CC(=C5OC)OC)C)OCO4)O</moldb-smiles>
  <moldb-formula>C23H26NO7+</moldb-formula>
  <moldb-inchi>InChI=1S/C23H25NO7/c1-12(25)31-22-14-5-6-16(27-3)21(28-4)15(14)10-24(2)8-7-13-9-17-23(30-11-29-17)20(26)18(13)19(22)24/h5-6,9,19,22H,7-8,10-11H2,1-4H3/p+1/t19-,22+,24?/m1/s1</moldb-inchi>
  <moldb-inchikey>UNFCTLFLKCGAOK-LOMQJKJHSA-O</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">428.1709272</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>2.2</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM331828</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>[(1r,21s)-3-hydroxy-16,17-dimethoxy-13-methyl-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaen-21-yl] acetate</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Alkaloids and derivatives</superklass>
  <klass>Protoberberine alkaloids and derivatives</klass>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0286401</sync-id>
  <structure-inchikey>UNFCTLFLKCGAOK-UHFFFAOYSA-O</structure-inchikey>
  <structure-fingerprint>1000000000000000000000200000000000000000000000000200000000000400000000000000000400400000040000000000000002000400000000000400000004000001000000000000000040000000020800000000100010000000000000000000000010000000040000005100000000000020000800000000000000880501011040040000000000280000208000000000000000000000000080000000020200200000000000044000000080000000000000000000000000000000000000080000000000000012000000000008000000000000000000000204200000000000090000000000000010040000000400400000000000020000000000000000800</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAfAAAAIwAAAIABBgBgAAAAAQMGACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:37:31Z</structure-indexed-at>
</compound>
